Clinical Trials Browser

Phase 3 × Breakthrough Pain × Fentanyl × Clear all

NCT00263575 2024-06-18

Long-term Safety Study of Sublingual Fentanyl Tablets in Cancer Patients

Phase 3 Completed

139 enrolled 7 charts

Neoplasms, Pain, Breakthrough Pain